MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    Is the sebum RNA transcriptome analysis technique capable of non-invasively diagnosing Parkinson’s disease?

    T. Iseki, Y. Ueda, T. Kuwano, T. Inoue, S. Saiki, N. Hattori (Bunkyo-ku, Japan)

    Objective: Our goal was to explore the potential of skin-surface lipid RNA transcriptome analysis as a diagnostic tool for Parkinson's disease. Background: Seborrheic dermatitis is…
  • 2024 International Congress

    Reliability of Digital Measures in Parkinson’s Disease and Their Implications for Sample Size Calculations

    J. Lavine, A. Scotina, S. Haney, E. Izmailova, L. Omberg (New York, USA)

    Objective: Assess the reliability and measurement error of measures derived from digital health technologies (DHTs) in Parkinson’s Disease (PD) patients and estimate sample size for…
  • 2024 International Congress

    Empower-PD: “An Exploratory Investigation of Accelerometer Data on Parkinson’s Patients’ Motor Symptoms and the Correlation with Quality of Life.”

    M. Hansen, B. Sørensen, T. Thomsen, N. Karottki (Copenhagen, Denmark)

    Objective: To describe weekly changes in bradykinesia-score (BKS) measured on objective wearable data and assess the correlation between these changes and Quality of Life (QoL)…
  • 2024 International Congress

    Evaluating the Effect of Myofascial Release on Parkinson’s Related Tremor

    S. Phelps (Cardiff, United Kingdom)

    Objective: Parkinson’s disease (PD) is the second-fastest neurological disorders in the world. Although there is no cure, medicines, surgical treatment, and other therapies can treat…
  • 2024 International Congress

    The First of Its Kind Genetics Cohort: the Black and African American Connections to Parkinson’s Disease (BLAAC PD) Study

    N. Louie, J. Solle, S. Bandrés-Ciga (New York, USA)

    Objective: Recruit and characterize a Black and African American (BAA) cohort to better understand Parkinson’s disease (PD). Background: A significant gap exists in our understanding…
  • 2024 International Congress

    Genetic Modifiers of Age at Onset for Parkinson’s Disease in Chinese Population

    H. Pan, L. Liu, J. Guo, B. Tang, Y. Zhao (Changsha, China)

    Objective: This study aimed to identify novel genetic modifiers of age at onset (AAO) for Parkinson’s disease (PD) including common variants and rare variants using…
  • 2024 International Congress

    Parkinson’s Disease Risk Genotypes at the GPNMB Locus Associate with Extent of Post-mortem Lewy Pathology

    E. Brody, E. Suh, V. van Deerlin, J. Trojanowski, E. Lee, A. Chen-Plotkin (PHILADELPHIA, USA)

    Objective: To determine whether Parkinson’s disease (PD) risk genotypes at the GPNMB locus associate with distribution of Lewy pathology in brain samples from a spectrum…
  • 2024 International Congress

    Association of Impulse Control Disorder with GRIN2B Gene Polymorphisims in Parkinson Disease

    G. Memari, E. Erzurumluoglu, N. Durmaz Celik, S. özkan, S. Artan (Eskisehir, Turkey)

    Objective: The aim of this study was to investigate the effect of GRIN2B gene rs1806201 and rs7301328 polymorphisms on the development of Impulse Control Disorder…
  • 2024 International Congress

    Association of Liver Fibrosis with Motor Deficits in Parkinson’s Disease

    A. Zolin, H. Ooi, H. Sarva (New York, USA)

    Objective: To determine the impact of liver fibrosis on motor symptoms in Parkinson’s disease Background: Parkinson’s disease motor symptoms can vary with systemic illnesses [1,2].…
  • 2024 International Congress

    Maintaining Isometric Contraction in Parkinson’s Disease: Effect of PD-Medication on EMG Amplitude

    B. Afsharipour, F. Roy, M. Schindle, F. Ba, M. Gorassini, T. Sankar (Edmonton, Canada)

    Objective: To quantify muscle activity changes in PD with dopaminergic medication. Background: Parkinson's disease (PD) is characterized by motor symptoms that improve with dopaminergic medication.…
  • « Previous Page
  • 1
  • …
  • 107
  • 108
  • 109
  • 110
  • 111
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley